Market News
Financial market news for retail investors — clear, concise, and jargon-free.
2302 articles — page 12 of 192
StocksAlfa Laval Reports Mixed Q1 2026 Results Amid Currency Challenges
Alfa Laval's Q1 2026 earnings show stable performance despite currency fluctuations and invoicing delays.
StocksGE Vernova Exceeds Earnings Expectations in Q1 2026
GE Vernova's Q1 2026 results show significant earnings and revenue growth, boosting investor confidence.
StocksStifel Maintains Buy Rating on Wolverine World Wide, Sets Price Target at $25
Stifel reaffirms its positive outlook on Wolverine stock, highlighting recovery and growth potential.
StocksStifel Maintains Buy Rating on Danaher, Sets Price Target at $260
Stifel reaffirms its Buy rating for Danaher Corp, noting mixed quarterly results but positive long-term outlook.
StocksStifel Maintains Buy Rating on Zymeworks Amid Positive Drug Data
Stifel reaffirms a Buy rating for Zymeworks after promising data on its ZW191 drug candidate.
StocksBofA Maintains Buy Rating on GE Vernova Amid Strong Order Growth
BofA Securities reaffirms a Buy rating for GE Vernova, highlighting impressive order growth and financial performance.
StocksStifel Maintains $670 Price Target for Intuitive Surgical After Strong Q1 Results
Stifel keeps a Buy rating and $670 target for Intuitive Surgical, highlighting strong earnings and growth.
StocksStifel Maintains Buy Rating on Zurn Water Solutions After Strong Q1 Results
Stifel reaffirms its Buy rating on Zurn Water Solutions following a strong first-quarter performance.
EconomyTSX Futures Rise Following Trump’s Iran Ceasefire Announcement
Canadian stock futures increased as Trump extended the Iran ceasefire, amid oil supply concerns.
StocksGuggenheim Maintains Buy Rating on TKO Group with $232 Price Target
Guggenheim reaffirms a Buy rating for TKO Group Holdings, citing potential for growth despite minor revenue adjustments.
StocksOppenheimer Maintains Perform Rating on Intuitive Surgical After Strong Q1 Results
Oppenheimer keeps a Perform rating on Intuitive Surgical, noting strong Q1 revenue and earnings despite market challenges.
StocksTruist Increases Albemarle's Stock Price Target Amid Strong Lithium Demand
Truist raises Albemarle's price target to $245, citing robust lithium demand and earnings growth potential.